
Johnathan Canton
@cantonjohnathan
Assistant Professor at the University of Calgary.
@cantonjohnathan.bsky.social
ID: 1400118768550903808
https://vet.ucalgary.ca/labs/cantonlab/home 02-06-2021 15:55:08
215 Tweet
247 Followers
242 Following

Early Career Investigators Dr. Ajitha Thanabalasuriar (Ajitha Thanabalasuriar) and Dr. Johnathan Canton (Johnathan Canton) present outstanding research made possible by CIHR funding 🎉 #CSI2024


MIID and UCalgaryMedicine Snyder Institute for Chronic Diseases @ucalgaryvetmed represented at #CSI2024


Pleasure to attend and host the Bhagi Singh Award session at the 36th #CSI2024 conference in Banff! Special thanks to Ajitha Thanabalasuriar & Johnathan Canton for highlighting excellence in #ECR research and to the fantastic organizing committee for partnering with CIHR-III | IRSC-IMII. Markus



Expanding the plasma membrane in #neutrophils and #macrophages increases their ability to engulf bacteria, fungi, and #cancer cells. UC San Francisco Memorial Sloan Kettering Cancer Center Learn more: scim.ag/7fY


Still early days, but this was a nice opportunity to take stock of the journey so far. Thanks for the invite Adrian Liston and ICB - the journal. And a nod to Belizean scientists Francis Fonseca @belizemoecst onlinelibrary.wiley.com/doi/full/10.11…


Great summary of our paper news.ucsb.edu/2024/021575/ap… 🙏 UC Santa Barbara




And a nice tweetorial from first author Gerone Gonzales 😊

New research in Science #Immunology identifies the pore-forming protein #APOL7C as a driver of phagosomal rupture and antigen cross-presentation in activated dendritic cells. Johnathan Canton Gerone Gonzales Liam Wilkinson Cassie Wood bit.ly/3CjeKWp



Research from Dr. Jonathan Canton and his team sheds light on how specialized immune cells act as sentinels, providing a critical defense against infections. ucalgary.ca/news/ucalgary-… #Immunology #PublicHealth U Calgary UCalgaryMedicine @ucalgaryvetmed Johnathan Canton Gerone Gonzales

🎉 Celebrating the tremendous developments in immunotherapy research led by Dr. Doug Mahoney and Charbonneau Cancer Institute researchers. The results of a generous $9.5M gift from the Canadian Cancer Society that has accelerated research for rare cancers. Read more: bit.ly/3YPGOIB


